366 related articles for article (PubMed ID: 31481662)
1. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.
Zhang F; Parayath NN; Ene CI; Stephan SB; Koehne AL; Coon ME; Holland EC; Stephan MT
Nat Commun; 2019 Sep; 10(1):3974. PubMed ID: 31481662
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
3. Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity.
Baer C; Squadrito ML; Laoui D; Thompson D; Hansen SK; Kiialainen A; Hoves S; Ries CH; Ooi CH; De Palma M
Nat Cell Biol; 2016 Jul; 18(7):790-802. PubMed ID: 27295554
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
[TBL] [Abstract][Full Text] [Related]
5. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype.
Dong H; Yang Y; Gao C; Sun H; Wang H; Hong C; Wang J; Gong F; Gao X
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217759
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy.
Wu X; Cheng Y; Zheng R; Xu K; Yan J; Song P; Wang Y; Rauf A; Pan Y; Zhang H
ACS Appl Mater Interfaces; 2021 May; 13(17):19825-19835. PubMed ID: 33881837
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity.
Perry CJ; Muñoz-Rojas AR; Meeth KM; Kellman LN; Amezquita RA; Thakral D; Du VY; Wang JX; Damsky W; Kuhlmann AL; Sher JW; Bosenberg M; Miller-Jensen K; Kaech SM
J Exp Med; 2018 Mar; 215(3):877-893. PubMed ID: 29436395
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses.
Wang YC; He F; Feng F; Liu XW; Dong GY; Qin HY; Hu XB; Zheng MH; Liang L; Feng L; Liang YM; Han H
Cancer Res; 2010 Jun; 70(12):4840-9. PubMed ID: 20501839
[TBL] [Abstract][Full Text] [Related]
11. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
Chen D; Xie J; Fiskesund R; Dong W; Liang X; Lv J; Jin X; Liu J; Mo S; Zhang T; Cheng F; Zhou Y; Zhang H; Tang K; Ma J; Liu Y; Huang B
Nat Commun; 2018 Feb; 9(1):873. PubMed ID: 29491374
[TBL] [Abstract][Full Text] [Related]
13. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
[TBL] [Abstract][Full Text] [Related]
14. Repolarization of Tumor-Associated Macrophages in a Genetically Engineered Nonsmall Cell Lung Cancer Model by Intraperitoneal Administration of Hyaluronic Acid-Based Nanoparticles Encapsulating MicroRNA-125b.
Parayath NN; Parikh A; Amiji MM
Nano Lett; 2018 Jun; 18(6):3571-3579. PubMed ID: 29722542
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor associated macrophages (TAMs) via nanocarriers.
Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy.
Ramesh A; Kumar S; Nguyen A; Brouillard A; Kulkarni A
Nanoscale; 2020 Jan; 12(3):1875-1885. PubMed ID: 31903467
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming Tumor-Associated Macrophages by Nanoparticle-Based Reactive Oxygen Species Photogeneration.
Shi C; Liu T; Guo Z; Zhuang R; Zhang X; Chen X
Nano Lett; 2018 Nov; 18(11):7330-7342. PubMed ID: 30339753
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages.
Ortega RA; Barham WJ; Kumar B; Tikhomirov O; McFadden ID; Yull FE; Giorgio TD
Nanoscale; 2015 Jan; 7(2):500-10. PubMed ID: 25408159
[TBL] [Abstract][Full Text] [Related]
19. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
20. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
